Articles

Experts Ryan Subhan and Emily Phillips highlight early planning, market education, and overcoming challenges in launching rare disease therapies. Watch now.
This video highlights the challenges of launching an expensive therapy for a rare disease, focusing on partnerships, planning, and tailored care. Watch now.
The video highlights the crucial role of advocacy groups and the importance of early, strategic planning for successfully launching rare disease treatments. Watch now.
The video outlines best planning, timing, and budgeting practices in rare disease product launches. Watch here.
In this video, experts Kapil Raina, Chris Zealey, and Brian Williams, explore insights on successfully launching products in rare disease markets.
The video outlines key success factors in rare disease markets through the five P's: People, Product, Payers, Promotion, and Placement. Watch here.
Gain insights from Chief Commercial Officers on launching in the rare disease market. Watch here.
Explore the rare disease landscape, focusing on patients' diagnostic and treatment challenges, competitive dynamics, and tailored launch strategies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
Today there is a laser focus on product performance out of the gate, so there is a lot of pressure to get it right. This means pharma companies need to make sure that they have the right launch team in place before putting together the structure and tactics in their launch plans. Read to learn more.
How can reps engage physicians beyond office visits in our digital world? Ultimately, this is what the launch teams need to answer when developing the ‘how to execute’ portion of their strategies.
Pharma companies that have product launches that repeatedly perform beyond expectations know how to develop vision and positioning, create a brand strategy with notable differentiation, and focus on building superior customer experiences. Learn more.
At Herspiegel, we have partnered with biotech and pharma companies big and small and have successfully brought millions of dollars worth of drugs, devices, and treatments to market. But before we get a product out the door, we help launch teams navigate their go-to-market strategies.
Complete Response Letters (CRLs) are increasing. How are pharma companies preparing? Read more.
Explore Herspiegel's expert strategies for successful rare disease launches, from tech innovation to market responsiveness. Learn more now.
Master drug launch success! Herspiegel shares 4-part blog series on de-risking launch plans. Tap into our go-to-market model now.
Maximize portfolio impact! Learn key co-positioning strategies for products in our latest whitepaper. Boost performance now.
Master oncology product launches with key strategies for success. Learn vital planning & collaboration tips. Watch our presentation.
Discover cell & gene therapy launch secrets with Beth Schurman & Kate Reedy on Herspiegel Conversations. Watch now.
Uncover how the Inflation Reduction Act revolutionizes Medicare & drug prices. Stay ahead with Herspiegel's insights. Read now.
Navigate pharma's complex landscape with Herspiegel’s savvy drug launch forecasting. Discover strategies for success. Click to learn more.
Discover the vast impact of rare diseases affecting 30M Americans & the struggle for diagnosis. Dive deeper into their stories.

Case Studies

A mid-sized global pharmaceutical organization entered a co-commercialization agreement with a top-10 pharmaceutical organization to launch its first product in oncology.
Leading biotech engaged Herspiegel for critical oncology drug launch in a competitive market, showcasing a dedicated, innovative approach.
Dual-launch success in two areas! Herspiegel expertly guides Phase 3 asset to market. Discover our strategy's impact.
Explore Herspiegel's approach to Oncology Patient Journey Mapping for new cancer therapy launches. Learn about our innovative strategies.
Join our journey in guiding an oncology start-up towards successful first product launch with expert strategies. Discover our impact.
Maximize your biopharma product's commercial success! Discover how Herspiegel's refined development process can drive market results. Learn more now
Discover how Herspiegel's guidance powered a biopharma start-up's first Neurology asset launch, crafting their commercial triumph. Learn more.

White Papers

In this whitepaper, you will discover: The four most common challenges in cell and gene therapy commercialization. Methods to address common product launch challenges. Insights to accelerate and de-risk launch for cell and gene therapy treatments. Read more.
Unlock personalized drug launch success with Herspiegel's archetype strategies. Dive into tailored planning for impactful market entry.
Master drug launch excellence with our guide on 4 key elements. Download now to define markets, gain insights & strategize your brand.
Navigate your start-up's first pharma launch with confidence! Discover 4 key success factors in our guide. Start excelling today.
Maximize your portfolio's impact with our guide on effective co-positioning strategies for healthcare products. Elevate your launch now.
Learn from our $60B success! Discover Herspiegel's proven 4-step model for pharma go-to-market strategies. Boost your launch now.
Facing a CRL can be daunting. Get insights on trends and tactics to mitigate its impact with our expert paper. Use this guide today.
Discover how to successfully commercialize cell & gene therapies. Learn from past challenges – Access our insights for a winning strategy now.

All Resources

Experts Ryan Subhan and Emily Phillips highlight early planning, market education, and overcoming challenges in launching rare disease therapies. Watch now.
This video highlights the challenges of launching an expensive therapy for a rare disease, focusing on partnerships, planning, and tailored care. Watch now.
The video highlights the crucial role of advocacy groups and the importance of early, strategic planning for successfully launching rare disease treatments. Watch now.
The video outlines best planning, timing, and budgeting practices in rare disease product launches. Watch here.
In this video, experts Kapil Raina, Chris Zealey, and Brian Williams, explore insights on successfully launching products in rare disease markets.
The video outlines key success factors in rare disease markets through the five P's: People, Product, Payers, Promotion, and Placement. Watch here.
Gain insights from Chief Commercial Officers on launching in the rare disease market. Watch here.
Explore the rare disease landscape, focusing on patients' diagnostic and treatment challenges, competitive dynamics, and tailored launch strategies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.
A mid-sized global pharmaceutical organization entered a co-commercialization agreement with a top-10 pharmaceutical organization to launch its first product in oncology.
Today there is a laser focus on product performance out of the gate, so there is a lot of pressure to get it right. This means pharma companies need to make sure that they have the right launch team in place before putting together the structure and tactics in their launch plans. Read to learn more.
How can reps engage physicians beyond office visits in our digital world? Ultimately, this is what the launch teams need to answer when developing the ‘how to execute’ portion of their strategies.
Pharma companies that have product launches that repeatedly perform beyond expectations know how to develop vision and positioning, create a brand strategy with notable differentiation, and focus on building superior customer experiences. Learn more.
At Herspiegel, we have partnered with biotech and pharma companies big and small and have successfully brought millions of dollars worth of drugs, devices, and treatments to market. But before we get a product out the door, we help launch teams navigate their go-to-market strategies.
In this whitepaper, you will discover: The four most common challenges in cell and gene therapy commercialization. Methods to address common product launch challenges. Insights to accelerate and de-risk launch for cell and gene therapy treatments. Read more.
Complete Response Letters (CRLs) are increasing. How are pharma companies preparing? Read more.
Explore Herspiegel's expert strategies for successful rare disease launches, from tech innovation to market responsiveness. Learn more now.
Master drug launch success! Herspiegel shares 4-part blog series on de-risking launch plans. Tap into our go-to-market model now.
Maximize portfolio impact! Learn key co-positioning strategies for products in our latest whitepaper. Boost performance now.
Master oncology product launches with key strategies for success. Learn vital planning & collaboration tips. Watch our presentation.
Discover cell & gene therapy launch secrets with Beth Schurman & Kate Reedy on Herspiegel Conversations. Watch now.
Leading biotech engaged Herspiegel for critical oncology drug launch in a competitive market, showcasing a dedicated, innovative approach.
Uncover how the Inflation Reduction Act revolutionizes Medicare & drug prices. Stay ahead with Herspiegel's insights. Read now.
Navigate pharma's complex landscape with Herspiegel’s savvy drug launch forecasting. Discover strategies for success. Click to learn more.
Dual-launch success in two areas! Herspiegel expertly guides Phase 3 asset to market. Discover our strategy's impact.
Explore Herspiegel's approach to Oncology Patient Journey Mapping for new cancer therapy launches. Learn about our innovative strategies.
Unlock personalized drug launch success with Herspiegel's archetype strategies. Dive into tailored planning for impactful market entry.
Discover the vast impact of rare diseases affecting 30M Americans & the struggle for diagnosis. Dive deeper into their stories.
Master drug launch excellence with our guide on 4 key elements. Download now to define markets, gain insights & strategize your brand.
Join our journey in guiding an oncology start-up towards successful first product launch with expert strategies. Discover our impact.
Navigate your start-up's first pharma launch with confidence! Discover 4 key success factors in our guide. Start excelling today.
Maximize your portfolio's impact with our guide on effective co-positioning strategies for healthcare products. Elevate your launch now.
Learn from our $60B success! Discover Herspiegel's proven 4-step model for pharma go-to-market strategies. Boost your launch now.
Facing a CRL can be daunting. Get insights on trends and tactics to mitigate its impact with our expert paper. Use this guide today.
Maximize your biopharma product's commercial success! Discover how Herspiegel's refined development process can drive market results. Learn more now
Discover how Herspiegel's guidance powered a biopharma start-up's first Neurology asset launch, crafting their commercial triumph. Learn more.
Discover how to successfully commercialize cell & gene therapies. Learn from past challenges – Access our insights for a winning strategy now.